Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
{{output}}
Alopecia areata (AA) is an autoimmune hair loss disorder, with Janus kinase inhibitors (JAKis) emerging as an effective treatment. However, concerns about malignancy risk remain due to boxed warnings primarily based on studies in rheumatoid arthritis. This ret... ...
